nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Ovarian cancer—Estropipate—osteoporosis	0.0915	0.0915	CcSEcCtD
Altretamine—Ovarian cancer—Raloxifene—osteoporosis	0.0886	0.0886	CcSEcCtD
Altretamine—Ovarian cancer—Conjugated Estrogens—osteoporosis	0.0605	0.0605	CcSEcCtD
Altretamine—Ovarian cancer—Estradiol—osteoporosis	0.0484	0.0484	CcSEcCtD
Altretamine—Neurological symptom—Pamidronate—osteoporosis	0.0395	0.0395	CcSEcCtD
Altretamine—Neoplasm malignant—Estropipate—osteoporosis	0.0186	0.0186	CcSEcCtD
Altretamine—Neoplasm malignant—Raloxifene—osteoporosis	0.018	0.018	CcSEcCtD
Altretamine—Neoplasm malignant—Calcitriol—osteoporosis	0.0174	0.0174	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Calcitriol—osteoporosis	0.0149	0.0149	CcSEcCtD
Altretamine—Neoplasm—Estropipate—osteoporosis	0.0144	0.0144	CcSEcCtD
Altretamine—Neoplasm malignant—Pamidronate—osteoporosis	0.014	0.014	CcSEcCtD
Altretamine—Neoplasm malignant—Zoledronate—osteoporosis	0.0128	0.0128	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Calcitriol—osteoporosis	0.0124	0.0124	CcSEcCtD
Altretamine—Neoplasm malignant—Conjugated Estrogens—osteoporosis	0.0123	0.0123	CcSEcCtD
Altretamine—Neoplasm—Ethinyl Estradiol—osteoporosis	0.0116	0.0116	CcSEcCtD
Altretamine—Neoplasm—Risedronate—osteoporosis	0.0113	0.0113	CcSEcCtD
Altretamine—Pancytopenia—Etidronic acid—osteoporosis	0.0109	0.0109	CcSEcCtD
Altretamine—Neuropathy peripheral—Etidronic acid—osteoporosis	0.0101	0.0101	CcSEcCtD
Altretamine—Anaemia—Ergocalciferol—osteoporosis	0.00997	0.00997	CcSEcCtD
Altretamine—Neoplasm—Zoledronate—osteoporosis	0.00985	0.00985	CcSEcCtD
Altretamine—Neoplasm malignant—Estradiol—osteoporosis	0.00983	0.00983	CcSEcCtD
Altretamine—Anorexia—Calcium Acetate—osteoporosis	0.0095	0.0095	CcSEcCtD
Altretamine—Neoplasm—Conjugated Estrogens—osteoporosis	0.00948	0.00948	CcSEcCtD
Altretamine—Neuropathy peripheral—Estropipate—osteoporosis	0.0087	0.0087	CcSEcCtD
Altretamine—Decreased appetite—Calcium Acetate—osteoporosis	0.00867	0.00867	CcSEcCtD
Altretamine—Anorexia—Ergocalciferol—osteoporosis	0.0084	0.0084	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Estradiol—osteoporosis	0.00839	0.00839	CcSEcCtD
Altretamine—Decreased appetite—Ergocalciferol—osteoporosis	0.00766	0.00766	CcSEcCtD
Altretamine—Neoplasm—Estradiol—osteoporosis	0.00759	0.00759	CcSEcCtD
Altretamine—Anaemia—Etidronic acid—osteoporosis	0.00741	0.00741	CcSEcCtD
Altretamine—Leukopenia—Etidronic acid—osteoporosis	0.00718	0.00718	CcSEcCtD
Altretamine—Asthenia—Calcium Acetate—osteoporosis	0.00715	0.00715	CcSEcCtD
Altretamine—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.00705	0.00705	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Estradiol—osteoporosis	0.00701	0.00701	CcSEcCtD
Altretamine—Dizziness—Calcium Acetate—osteoporosis	0.00659	0.00659	CcSEcCtD
Altretamine—Pancytopenia—Zoledronate—osteoporosis	0.00649	0.00649	CcSEcCtD
Altretamine—Vomiting—Calcium Acetate—osteoporosis	0.00634	0.00634	CcSEcCtD
Altretamine—Asthenia—Ergocalciferol—osteoporosis	0.00632	0.00632	CcSEcCtD
Altretamine—Anaemia—Alendronate—osteoporosis	0.00632	0.00632	CcSEcCtD
Altretamine—Vertigo—Estropipate—osteoporosis	0.00623	0.00623	CcSEcCtD
Altretamine—Anaemia—Ibandronate—osteoporosis	0.00615	0.00615	CcSEcCtD
Altretamine—Vertigo—Alendronate—osteoporosis	0.00614	0.00614	CcSEcCtD
Altretamine—Vertigo—Raloxifene—osteoporosis	0.00604	0.00604	CcSEcCtD
Altretamine—Vertigo—Ibandronate—osteoporosis	0.00598	0.00598	CcSEcCtD
Altretamine—Nausea—Calcium Acetate—osteoporosis	0.00592	0.00592	CcSEcCtD
Altretamine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00575	0.00575	CcSEcCtD
Altretamine—Convulsion—Calcitriol—osteoporosis	0.00564	0.00564	CcSEcCtD
Altretamine—Thrombocytopenia—Raloxifene—osteoporosis	0.00537	0.00537	CcSEcCtD
Altretamine—Nausea—Ergocalciferol—osteoporosis	0.00523	0.00523	CcSEcCtD
Altretamine—Anaemia—Risedronate—osteoporosis	0.00507	0.00507	CcSEcCtD
Altretamine—Anorexia—Calcitriol—osteoporosis	0.00507	0.00507	CcSEcCtD
Altretamine—Vertigo—Risedronate—osteoporosis	0.00493	0.00493	CcSEcCtD
Altretamine—Fatigue—Estropipate—osteoporosis	0.00488	0.00488	CcSEcCtD
Altretamine—Anaemia—Pamidronate—osteoporosis	0.00482	0.00482	CcSEcCtD
Altretamine—Decreased appetite—Ibandronate—osteoporosis	0.00472	0.00472	CcSEcCtD
Altretamine—Fatigue—Ibandronate—osteoporosis	0.00468	0.00468	CcSEcCtD
Altretamine—Leukopenia—Pamidronate—osteoporosis	0.00467	0.00467	CcSEcCtD
Altretamine—Decreased appetite—Calcitriol—osteoporosis	0.00462	0.00462	CcSEcCtD
Altretamine—Neuropathy peripheral—Estradiol—osteoporosis	0.0046	0.0046	CcSEcCtD
Altretamine—Convulsion—Pamidronate—osteoporosis	0.00452	0.00452	CcSEcCtD
Altretamine—Anaemia—Zoledronate—osteoporosis	0.0044	0.0044	CcSEcCtD
Altretamine—Vertigo—Zoledronate—osteoporosis	0.00428	0.00428	CcSEcCtD
Altretamine—Leukopenia—Zoledronate—osteoporosis	0.00426	0.00426	CcSEcCtD
Altretamine—Thrombocytopenia—Pamidronate—osteoporosis	0.00417	0.00417	CcSEcCtD
Altretamine—Vomiting—Etidronic acid—osteoporosis	0.00416	0.00416	CcSEcCtD
Altretamine—Convulsion—Zoledronate—osteoporosis	0.00413	0.00413	CcSEcCtD
Altretamine—Vertigo—Conjugated Estrogens—osteoporosis	0.00412	0.00412	CcSEcCtD
Altretamine—Asthenia—Estropipate—osteoporosis	0.00406	0.00406	CcSEcCtD
Altretamine—Anorexia—Pamidronate—osteoporosis	0.00406	0.00406	CcSEcCtD
Altretamine—Asthenia—Alendronate—osteoporosis	0.004	0.004	CcSEcCtD
Altretamine—Convulsion—Conjugated Estrogens—osteoporosis	0.00397	0.00397	CcSEcCtD
Altretamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00396	0.00396	CcSEcCtD
Altretamine—Asthenia—Ibandronate—osteoporosis	0.0039	0.0039	CcSEcCtD
Altretamine—Nausea—Etidronic acid—osteoporosis	0.00389	0.00389	CcSEcCtD
Altretamine—Fatigue—Risedronate—osteoporosis	0.00386	0.00386	CcSEcCtD
Altretamine—Asthenia—Calcitriol—osteoporosis	0.00381	0.00381	CcSEcCtD
Altretamine—Thrombocytopenia—Zoledronate—osteoporosis	0.0038	0.0038	CcSEcCtD
Altretamine—Dizziness—Estropipate—osteoporosis	0.00374	0.00374	CcSEcCtD
Altretamine—Anorexia—Zoledronate—osteoporosis	0.0037	0.0037	CcSEcCtD
Altretamine—Decreased appetite—Pamidronate—osteoporosis	0.0037	0.0037	CcSEcCtD
Altretamine—Dizziness—Alendronate—osteoporosis	0.00369	0.00369	CcSEcCtD
Altretamine—Fatigue—Pamidronate—osteoporosis	0.00367	0.00367	CcSEcCtD
Altretamine—Dizziness—Raloxifene—osteoporosis	0.00363	0.00363	CcSEcCtD
Altretamine—Vomiting—Estropipate—osteoporosis	0.0036	0.0036	CcSEcCtD
Altretamine—Dizziness—Ibandronate—osteoporosis	0.00359	0.00359	CcSEcCtD
Altretamine—Anorexia—Conjugated Estrogens—osteoporosis	0.00357	0.00357	CcSEcCtD
Altretamine—Vomiting—Alendronate—osteoporosis	0.00355	0.00355	CcSEcCtD
Altretamine—Vomiting—Raloxifene—osteoporosis	0.00349	0.00349	CcSEcCtD
Altretamine—Vomiting—Ibandronate—osteoporosis	0.00345	0.00345	CcSEcCtD
Altretamine—Vomiting—Calcitriol—osteoporosis	0.00338	0.00338	CcSEcCtD
Altretamine—Decreased appetite—Zoledronate—osteoporosis	0.00338	0.00338	CcSEcCtD
Altretamine—Nausea—Estropipate—osteoporosis	0.00336	0.00336	CcSEcCtD
Altretamine—Fatigue—Zoledronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Altretamine—Nausea—Alendronate—osteoporosis	0.00331	0.00331	CcSEcCtD
Altretamine—Vertigo—Estradiol—osteoporosis	0.0033	0.0033	CcSEcCtD
Altretamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00329	0.00329	CcSEcCtD
Altretamine—Nausea—Raloxifene—osteoporosis	0.00326	0.00326	CcSEcCtD
Altretamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00325	0.00325	CcSEcCtD
Altretamine—Fatigue—Conjugated Estrogens—osteoporosis	0.00323	0.00323	CcSEcCtD
Altretamine—Nausea—Ibandronate—osteoporosis	0.00323	0.00323	CcSEcCtD
Altretamine—Asthenia—Risedronate—osteoporosis	0.00321	0.00321	CcSEcCtD
Altretamine—Nausea—Calcitriol—osteoporosis	0.00316	0.00316	CcSEcCtD
Altretamine—Asthenia—Pamidronate—osteoporosis	0.00305	0.00305	CcSEcCtD
Altretamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00304	0.00304	CcSEcCtD
Altretamine—Dizziness—Risedronate—osteoporosis	0.00296	0.00296	CcSEcCtD
Altretamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00292	0.00292	CcSEcCtD
Altretamine—Vomiting—Risedronate—osteoporosis	0.00285	0.00285	CcSEcCtD
Altretamine—Dizziness—Pamidronate—osteoporosis	0.00281	0.00281	CcSEcCtD
Altretamine—Asthenia—Zoledronate—osteoporosis	0.00279	0.00279	CcSEcCtD
Altretamine—Nausea—Ethinyl Estradiol—osteoporosis	0.00273	0.00273	CcSEcCtD
Altretamine—Vomiting—Pamidronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Altretamine—Asthenia—Conjugated Estrogens—osteoporosis	0.00268	0.00268	CcSEcCtD
Altretamine—Nausea—Risedronate—osteoporosis	0.00266	0.00266	CcSEcCtD
Altretamine—Decreased appetite—Estradiol—osteoporosis	0.0026	0.0026	CcSEcCtD
Altretamine—Fatigue—Estradiol—osteoporosis	0.00258	0.00258	CcSEcCtD
Altretamine—Dizziness—Zoledronate—osteoporosis	0.00257	0.00257	CcSEcCtD
Altretamine—Nausea—Pamidronate—osteoporosis	0.00253	0.00253	CcSEcCtD
Altretamine—Dizziness—Conjugated Estrogens—osteoporosis	0.00247	0.00247	CcSEcCtD
Altretamine—Vomiting—Zoledronate—osteoporosis	0.00247	0.00247	CcSEcCtD
Altretamine—Vomiting—Conjugated Estrogens—osteoporosis	0.00238	0.00238	CcSEcCtD
Altretamine—Nausea—Zoledronate—osteoporosis	0.00231	0.00231	CcSEcCtD
Altretamine—Nausea—Conjugated Estrogens—osteoporosis	0.00222	0.00222	CcSEcCtD
Altretamine—Asthenia—Estradiol—osteoporosis	0.00215	0.00215	CcSEcCtD
Altretamine—Dizziness—Estradiol—osteoporosis	0.00198	0.00198	CcSEcCtD
Altretamine—Vomiting—Estradiol—osteoporosis	0.0019	0.0019	CcSEcCtD
Altretamine—Nausea—Estradiol—osteoporosis	0.00178	0.00178	CcSEcCtD
